Accessibility Menu
Eagle Pharmaceuticals Stock Quote

Eagle Pharmaceuticals (OTC: EGRX)

$1.00
(0.0%)
+0.00
Price as of October 22, 2025, 3:47 p.m. ET

KEY DATA POINTS

Current Price
$1
Daily Change
(0.0%) +$0.00
Day's Range
$1 - $1
Previous Close
$1
Open
$1
Beta
0.64
Volume
600
Average Volume
1,826
Market Cap
13M
Market Cap / Employee
$1.00M
52wk Range
$0 - $3.87
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
$0
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Eagle Pharmaceuticals Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
EGRX+42.86%-97.89%-53.8%-92%
S&P+15.06%+95.03%+14.29%+270%

Eagle Pharmaceuticals Company Info

Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.

News & Analysis

Financial Health

General

No data available for this period.

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

No data available for this period.

Liabilities

No data available for this period.

Ratios

No data available for this period.

Cash Flow

No data available for this period.

Valuation

MetricYoY Change

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.